骨质疏松症基层合理用药指南

2021-05-30 中华医学会 中华全科医师杂志.2021.20(5):523-529.

骨质疏松症是一种以骨量低、骨组织微结构损坏为表现,导致骨脆性增加、易发生骨折为特征的全身性代谢性骨病。骨质疏松症可发生于任何年龄,但多见于绝经后女性和老年男性。骨质疏松症按病因分为原发性和继发性两大类

中文标题:

骨质疏松症基层合理用药指南

发布机构:

中华医学会

发布日期:

2021-05-30

简要介绍:

骨质疏松症是一种以骨量低、骨组织微结构损坏为表现,导致骨脆性增加、易发生骨折为特征的全身性代谢性骨病。骨质疏松症可发生于任何年龄,但多见于绝经后女性和老年男性。骨质疏松症按病因分为原发性和继发性两大类,本指南主要针对原发性骨质疏松症。

相关资料下载:
[AttachmentFileName(sort=1, fileName=骨质疏松症基层合理用药指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ab7e21c002121eb9, title=骨质疏松症基层合理用药指南, enTitle=, guiderFrom=中华全科医师杂志.2021.20(5):523-529., authorId=0, author=, summary=骨质疏松症是一种以骨量低、骨组织微结构损坏为表现,导致骨脆性增加、易发生骨折为特征的全身性代谢性骨病。骨质疏松症可发生于任何年龄,但多见于绝经后女性和老年男性。骨质疏松症按病因分为原发性和继发性两大类, cover=https://img.medsci.cn/2021630/1625064918088_2020535.jpg, journalId=0, articlesId=null, associationId=359, associationName=中华医学会, associationIntro=中华医学会是中国医学科学技术工作者自愿组成并依法登记成立的学术性、公益性、非营利性法人社团,是党和国家联系医学科技工作者的桥梁和纽带,是发展中国医学科学技术事业的重要社会力量。 中华医学会(Chinese Medical Association)成立于1915年。现有83个专科分会,50万名会员,下设部门16个,法人实体机构3个,另与解放军军事医学科学院合办医学图书馆1个。 中华医学会的主要业务包括:开展医学学术交流;编辑出版123种医学、科普等各类期刊及100余种音像出版物;开展继续医学教育;开展国际间学术交流;开展医学科技项目的评价、评审和医学科学技术决策论证;评选和奖励优秀医学科技成果(包括学术论文和科普作品等);开展专科医师的培训和考核;发现、推荐和培养优秀医学科技人才;宣传、奖励医德高尚、业务精良的医务人员;承担政府委托职能及承办委托任务;设立临床研究专项资金,提高临床科研水平;组织医疗事故技术鉴定和预防接种异常反应技术鉴定工作;推动医学科研成果的转化和应用;向党和政府反映医学科技工作者的意见和要求。, copyright=0, guiderPublishedTime=Sun May 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>骨质疏松症是一种以骨量低、骨组织微结构损坏为表现,导致骨脆性增加、易发生骨折为特征的全身性代谢性骨病。骨质疏松症可发生于任何年龄,但多见于绝经后女性和老年男性。骨质疏松症按病因分为原发性和继发性两大类,本指南主要针对原发性骨质疏松症。</p> </div> </div> </div>, tagList=[TagDto(tagId=644, tagName=骨质疏松症)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21067, categoryName=梅斯医学-骨质疏松网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=644, guiderKeyword=骨质疏松症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6748, appHits=635, showAppHits=0, pcHits=919, showPcHits=6104, likes=2, shares=94, comments=28, approvalStatus=1, publishedTime=Wed Jun 30 23:53:41 CST 2021, publishedTimeString=2021-05-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Jun 30 22:55:33 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 04:10:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=骨质疏松症基层合理用药指南.pdf)])
骨质疏松症基层合理用药指南.pdf
下载请点击:
评论区 (19)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1222423, encodeId=1d671222423e9, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:30:55 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214734, encodeId=d28f1214e3491, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:48:14 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191306, encodeId=21e311913064d, content=谢谢提供指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e82168578, createdName=Emma1234, createdTime=Wed Feb 09 07:34:19 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181481, encodeId=fa371181481b3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85885577571, createdName=ms9000001761409400, createdTime=Thu Jan 06 19:56:36 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071344, encodeId=598b10e134428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e675610548, createdName=ms8000001322546615, createdTime=Thu Nov 18 10:40:54 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2022-05-25 自此烟雨落盛京

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1222423, encodeId=1d671222423e9, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:30:55 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214734, encodeId=d28f1214e3491, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:48:14 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191306, encodeId=21e311913064d, content=谢谢提供指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e82168578, createdName=Emma1234, createdTime=Wed Feb 09 07:34:19 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181481, encodeId=fa371181481b3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85885577571, createdName=ms9000001761409400, createdTime=Thu Jan 06 19:56:36 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071344, encodeId=598b10e134428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e675610548, createdName=ms8000001322546615, createdTime=Thu Nov 18 10:40:54 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    ***

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1222423, encodeId=1d671222423e9, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:30:55 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214734, encodeId=d28f1214e3491, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:48:14 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191306, encodeId=21e311913064d, content=谢谢提供指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e82168578, createdName=Emma1234, createdTime=Wed Feb 09 07:34:19 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181481, encodeId=fa371181481b3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85885577571, createdName=ms9000001761409400, createdTime=Thu Jan 06 19:56:36 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071344, encodeId=598b10e134428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e675610548, createdName=ms8000001322546615, createdTime=Thu Nov 18 10:40:54 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2022-02-09 Emma1234

    谢谢提供指南

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1222423, encodeId=1d671222423e9, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:30:55 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214734, encodeId=d28f1214e3491, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:48:14 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191306, encodeId=21e311913064d, content=谢谢提供指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e82168578, createdName=Emma1234, createdTime=Wed Feb 09 07:34:19 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181481, encodeId=fa371181481b3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85885577571, createdName=ms9000001761409400, createdTime=Thu Jan 06 19:56:36 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071344, encodeId=598b10e134428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e675610548, createdName=ms8000001322546615, createdTime=Thu Nov 18 10:40:54 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2022-01-06 ms9000001761409400

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1222423, encodeId=1d671222423e9, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:30:55 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214734, encodeId=d28f1214e3491, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:48:14 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191306, encodeId=21e311913064d, content=谢谢提供指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e82168578, createdName=Emma1234, createdTime=Wed Feb 09 07:34:19 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181481, encodeId=fa371181481b3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85885577571, createdName=ms9000001761409400, createdTime=Thu Jan 06 19:56:36 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071344, encodeId=598b10e134428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e675610548, createdName=ms8000001322546615, createdTime=Thu Nov 18 10:40:54 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2021-11-18 ms8000001322546615

    学习了

    0

拓展阅读

2017 ACP临床实践指南:治疗低骨密度或骨质疏松症预防骨折

美国医学会(AMA,American Medical Association) · 2017-05-09

2017 SIOT临床指南:骨质疏松症的预防和治疗

意大利骨科和创伤外科学会(SIOT,Italian Society for Orthopaedics and Traumatology) · 2017-10-20

2018 法国绝经后骨质疏松症的管理建议(更新版)

法国风湿病学学会(SFR,French Society for Rheumatology) · 2018-04-11

2019 TES临床实践指南:女性绝经后骨质疏松症的药物治疗

美国内分泌学会(TES,The Endocrine Society) · 2019-03-25